Mehta Piyush

CHRO Piyush Mehta sells 76,902 shares of Genpact (G) for $3,274,487.16 in two transactions at $42.58

Mehta Piyush, Senior Vice President and CHRO, executed two separate open-market sales totaling 76,902 shares for $3,274,487.16 at a blended average price of $42.58. The sale reduced his holdings by 36.3%, from 211,782 shares to 134,880 shares post-transaction. His cross-ticker track record shows mixed timing: 8 prior sells averaged -0.4% 30-day return and -0.9% 90-day return, with a 37.50% well-timed rate. At Genpact specifically, his prior 5 sales have produced positive 90-day returns in 100% of measurable cases, indicating he has historically sold ahead of subsequent gains at this ticker. The stock currently trades at $42.11, only 0.11% below the transaction price, and is down 24.2% from its 52-week high of $55.54, suggesting the timing of this sale near recent lows differs from his prior Genpact sell pattern.

Genpact CHRO Mehta sold 12,000 shares at $42.83 on 2025-01-10 for $513,960; retains 151,182 shares.

Mehta Piyush, Senior Vice President and CHRO, sold 12,000 shares of Genpact (representing a -7.4% reduction in his prior holdings of 163,182 shares) at $42.83 per share on 2025-01-10. The sale occurred when the stock was -5.6% from its 52-week high of $46.82, and the current price of $44.20 suggests modest downside since the transaction. His cross-ticker track record shows a 50.00% well-timed rate on sells with an average 90-day return of -5.6%, indicating moderate historical accuracy in timing sell decisions. At the same ticker G, however, his prior 4 measurable sells show only 1 of 4 were well-timed (25% rate), with mostly positive 90-day returns (ranging from -0.6% to +1.8%), suggesting his historical selling at this company has been consistently poorly timed. The company's valuation remains modest (P/E 11.76) with solid underlying fundamentals ($1.2B in revenue, 2.4% annual growth), which limits the signal strength of a single insider sale.

Genpact CHRO Piyush Mehta sold 70,000 shares at $46.46; retains 163,049 shares post-transaction.

Piyush Mehta, Senior Vice President and CHRO, sold 70,000 shares (70.0K shares) of Genpact LTD (G) at $46.46 on 2024-11-12, reducing his holdings by 30.0% to 163,049 shares. At the transaction price of $46.46, the sale occurred near the 52-week high of $46.67, and the stock has since declined 3.4% to a current price of $45.10. His cross-ticker track record shows 6 prior sells with a 90-day well-timed rate of 50.00%, while his prior 5 trades at Genpact specifically resulted in 2 well-timed sells at the 90-day mark, indicating mixed timing precision at this ticker. The company trades at a P/E of 11.99 with recent quarterly revenue of $1.2B and annual revenue growth of 2.4%, positioning it in a modest-growth profile; the sale itself—a significant reduction in executive holdings—warrants observation but does not alone indicate an earnings or strategic inflection point.